Research Education

What Is GHK-Cu? A Research Overview of the Copper Tripeptide

Aūra Research · laboratory reference

GHK-Cu is one of the most heavily cited copper-binding peptides in the laboratory literature. It has appeared in cell culture, gene expression and animal studies for more than four decades. Citation volume is not the same as evidence strength, and the two are easy to confuse here.

This overview covers what the molecule is, which research areas report it, and how those studies were designed. It describes published findings only.

What GHK-Cu is

GHK was first isolated from human plasma fractions in the 1970s. The sequence is short and unstructured, which makes it straightforward to synthesise and easy to characterise by mass spectrometry.

Coordination chemistry explains most of the interest in it. The copper ion is held by the histidine imidazole nitrogen, the terminal amine and the peptide backbone. Bound copper behaves differently in culture from free copper salts, which is why side-by-side comparisons of GHK-Cu against the uncomplexed peptide recur throughout the published work.

What the research looked at

The findings below are stated as they were published, attributed to the model system that produced them. None were measured in humans.

Research area	Model system	Measured endpoint
Matrix synthesis	Cultured fibroblasts, in vitro	Collagen synthesis versus untreated controls
Matrix turnover	Cultured fibroblasts, in vitro	Matrix metalloproteinase-2 expression
Epidermal biology	Keratinocyte monolayer and skin equivalents	Proliferation, integrin expression, p63 positivity
Gene expression	Human fibroblasts, emphysematous lung tissue	Transcriptomic signature, collagen I gel contraction
Inflammation and fibrosis	Murine silicosis model	Lung inflammation and fibrosis markers, peroxiredoxin 6 binding

Matrix biology and skin models

Matrix biology carries the oldest and largest body of work. Early fibroblast culture experiments reported increased collagen synthesis in the presence of the tripeptide-copper complex compared with untreated controls (Maquart et al., 1988). Later work in the same field reported that the complex raised matrix metalloproteinase-2 expression in cultured fibroblasts (Siméon et al., 2000).

Those two results sit on opposite sides of matrix turnover, synthesis and degradation, which is a recurring feature of this literature rather than a contradiction.

Dermatological groups moved the question into layered tissue. Copper-GHK increased proliferation in keratinocyte monolayer culture, while raised integrin alpha-6 and beta-1 expression and higher p63 positivity appeared in three-dimensional skin-equivalent models rather than in monolayer (Kang et al., 2009). The model system changed the readout.

Transcriptomics and animal work

One study approached the peptide without a preselected endpoint. Investigators identified a gene signature of emphysema-related lung destruction, then screened computationally for compounds whose expression profiles ran counter to it. GHK was returned by the screen. In follow-up laboratory work the authors reported cytoskeletal organisation, elevated integrin beta-1 expression and restored collagen I contraction in fibroblasts from diseased lungs (Campbell et al., 2012).

Recent animal work went after a mechanism. In a murine silicosis model, the GHK-Cu complex attenuated markers of lung inflammation and fibrosis, and the authors proposed peroxiredoxin 6 as a molecular target on the basis of binding and knockdown experiments (Bian et al., 2024). These were findings in animals and cell systems only.

Reading this literature carefully

Reproducible work starts with well-characterised material. Aūra Research supplies third-party tested GHK-Cu alongside the rest of the best sellers range, with batch purity data published before the first experiment.

All products sold by Aūra Research are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use.